We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Zumiez's (ZUMZ) Earnings Continue to Increase in Q3?
Read MoreHide Full Article
Zumiez Inc. (ZUMZ - Free Report) is scheduled to report third-quarter fiscal 2019 results on Dec 5, after the closing bell. We note that in the trailing four quarters, the company’s bottom line outperformed the Zacks Consensus Estimate by 60.9%, on average. In the last reported quarter, the company beat the consensus mark by a wide margin.
What to Expect This Time
The Zacks Consensus Estimate for third-quarter earnings has remained unchanged over the past 30 days at 59 cents. This suggests a rise of 7.3% from the year-ago quarter’s reported figure. Management had guided third-quarter earnings of 55-61 cents a share.
For revenues, the consensus mark is pegged at $260.4 million, indicating an increase of 4.7% from the figure reported in the year-ago quarter.
Zumiez has been focusing on providing differentiated assortments, expanding its store base and implementing advanced technology to augment customers’ shopping experience across diverse channels. Further, it has been boosting competitiveness by making investments in logistics, planning and allocation.
Also, the company has been expanding e-commerce and omni-channel platforms to provide consumers with the facility of quick and easy access to its products and brands. It considerably improved customers’ experience by integrating its physical and digital networks. This, in turn, allows customers to access inventories through all channels alongside availing facilities like buy online, pick up in store, reserve online and pay in store. These factors have been aiding the company’s top-line performance.
In the last earnings call, the company projected comps growth of 3-5% and net sales between $258 million and $263 million for the quarter under review. Furthermore, management expects consolidated operating margin of 7-7.7% for the third quarter compared with 7.4% reported in the same period last year. We believe that any increase in SG&A expenses on account of store openings may hurt margin to an extent.
What the Zacks Model Predicts
Our proven model does not conclusively predict an earnings beat for Zumiez this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zumiez carries a Zacks Rank #3 but has an Earnings ESP of 0.00%.
Stocks Poised to Beat Earnings Estimates
Here are a few companies you may want to consider, as our model shows that these have the right combination to post an earnings beat:
Dollar General (DG - Free Report) has an Earnings ESP of +0.65% and a Zacks Rank #2.
Big Lots, Inc. has an Earnings ESP of +3.85% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Will Zumiez's (ZUMZ) Earnings Continue to Increase in Q3?
Zumiez Inc. (ZUMZ - Free Report) is scheduled to report third-quarter fiscal 2019 results on Dec 5, after the closing bell. We note that in the trailing four quarters, the company’s bottom line outperformed the Zacks Consensus Estimate by 60.9%, on average. In the last reported quarter, the company beat the consensus mark by a wide margin.
What to Expect This Time
The Zacks Consensus Estimate for third-quarter earnings has remained unchanged over the past 30 days at 59 cents. This suggests a rise of 7.3% from the year-ago quarter’s reported figure. Management had guided third-quarter earnings of 55-61 cents a share.
For revenues, the consensus mark is pegged at $260.4 million, indicating an increase of 4.7% from the figure reported in the year-ago quarter.
Zumiez Inc. Price, Consensus and EPS Surprise
Zumiez Inc. price-consensus-eps-surprise-chart | Zumiez Inc. Quote
Key Things to Note
Zumiez has been focusing on providing differentiated assortments, expanding its store base and implementing advanced technology to augment customers’ shopping experience across diverse channels. Further, it has been boosting competitiveness by making investments in logistics, planning and allocation.
Also, the company has been expanding e-commerce and omni-channel platforms to provide consumers with the facility of quick and easy access to its products and brands. It considerably improved customers’ experience by integrating its physical and digital networks. This, in turn, allows customers to access inventories through all channels alongside availing facilities like buy online, pick up in store, reserve online and pay in store. These factors have been aiding the company’s top-line performance.
In the last earnings call, the company projected comps growth of 3-5% and net sales between $258 million and $263 million for the quarter under review. Furthermore, management expects consolidated operating margin of 7-7.7% for the third quarter compared with 7.4% reported in the same period last year. We believe that any increase in SG&A expenses on account of store openings may hurt margin to an extent.
What the Zacks Model Predicts
Our proven model does not conclusively predict an earnings beat for Zumiez this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zumiez carries a Zacks Rank #3 but has an Earnings ESP of 0.00%.
Stocks Poised to Beat Earnings Estimates
Here are a few companies you may want to consider, as our model shows that these have the right combination to post an earnings beat:
Costco Wholesale Corporation (COST - Free Report) has an Earnings ESP of +1.01% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Dollar General (DG - Free Report) has an Earnings ESP of +0.65% and a Zacks Rank #2.
Big Lots, Inc. has an Earnings ESP of +3.85% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>